The Trump administration is deferring $1.3 billion in federal Medicaid funding to California while officials investigate fraud concerns tied to the state's hospice and home health agencies, according to a report by The California Post.
The deferral affects the federal government's share of California's Medicaid payments, which jointly funds the state's Medi-Cal program serving approximately 14 million low-income residents. Federal law requires states to maintain adequate safeguards against improper payments in federally-funded healthcare programs.
What the Right Is Saying
Administration officials have defended the deferral as a necessary response to documented concerns about improper payments in California's hospice and home health sectors. The Centers for Medicare and Medicaid Services (CMS) has authority to withhold federal matching funds when states fail to maintain adequate program integrity safeguards.
Republican lawmakers have supported the administration's approach, arguing that federal taxpayers should not fund programs where oversight appears insufficient. Some have pointed to broader concerns about Medicaid spending growth and the need for accountability in joint federal-state healthcare programs.
Conservatives have noted that California is not unique in facing scrutiny over hospice and home health billing practices, but argue the scale of potential improper payments justified immediate action. They contend that deferring funds while investigations proceed protects federal interests pending resolution of identified concerns.
What the Left Is Saying
Democratic lawmakers from California have pushed back on the funding deferral, arguing that patients relying on Medi-Cal coverage should not bear the consequences of alleged fraud by healthcare providers. State officials have noted that California has been cooperating with federal investigators and has its own mechanisms to pursue fraudulent actors within the program.
California Governor Gavin Newsom's office has indicated the state is working to address any identified deficiencies while ensuring continuity of care for beneficiaries. Advocates for low-income residents have raised concerns about potential disruptions to services for vulnerable populations, including elderly patients in hospice care and individuals receiving home health services.
Progressive groups have argued that targeted enforcement against specific fraudulent providers would be less disruptive than broad funding deferrals affecting the entire state's Medicaid program. They note that California has expanded Medi-Cal coverage under state initiatives and suggest federal action may complicate those efforts.
What the Numbers Show
California's Medi-Cal program covers approximately 14 million residents, making it one of the largest Medicaid programs in the country. The state budget includes roughly $12 billion in annual federal matching funds for Medi-Cal, meaning the deferred $1.3 billion represents approximately 11% of total federal Medicaid contributions to California.
Hospice and home health services have been areas of national concern for improper payments. According to CMS data, Medicare hospice improper payment rates have exceeded 10% in recent years, with similar challenges identified in home health programs under both Medicare and Medicaid.
The specific fraud allegations in California reportedly center on billing practices at certain hospice agencies and home health providers. State licensing records show California's hospice industry has grown significantly over the past decade, with thousands of licensed facilities serving an aging population.
Federal law allows CMS to defer federal matching funds when states are found to have inadequate program integrity measures. The specific timeline for resolving the California deferral has not been publicly disclosed by either federal or state officials.
The Bottom Line
The $1.3 billion Medicaid funding deferral represents a significant financial action affecting California's healthcare system, which serves roughly one-third of the state's population through Medi-Cal. The move underscores ongoing tensions between the Trump administration and California over program oversight and accountability.
What happens next will depend on negotiations between state officials and CMS regarding what steps California must take to address fraud concerns before federal funds are released. Patients currently receiving hospice or home health services under Medi-Cal may face uncertainty during this period, though state officials have indicated they are working to minimize service disruptions.
Key questions remain unanswered: What specific fraudulent activities triggered the deferral? How long might funding be held? What safeguards is California being asked to implement? Watch for announcements from CMS and California's Health Care Services Department regarding the terms of any resolution. The outcome could set precedent for how the administration handles similar concerns in other large Medicaid states.